The bill, S.B. No. 1983, introduces new regulations concerning the manufacture, sale, and distribution of products developed using messenger ribonucleic acid (mRNA) material for the prevention or treatment of communicable diseases. It amends the Health and Safety Code by adding Section 431.0215, which defines "mRNA material" as a substance that introduces mRNA corresponding to a viral protein. The bill explicitly prohibits any person from manufacturing, selling, or distributing such products.

This legislation aims to establish additional prohibited acts related to mRNA products, reflecting a growing concern over the safety and regulation of these emerging biotechnologies. The provisions of the bill will take effect on September 1, 2025, allowing time for stakeholders to adjust to the new legal framework.

Statutes affected:
Introduced: ()